It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV

MeSH terms

• Adenosine Monophosphate / analogs & derivatives
• Adenosine Monophosphate / therapeutic use
• Alanine / analogs & derivatives
• Alanine / therapeutic use
• Antitubercular Agents / therapeutic use
• Antiviral Agents / therapeutic use
• Betacoronavirus / pathogenicity*
• COVID-19
• Coinfection
• Comorbidity
• Coronavirus Infections / drug therapy
• Coronavirus Infections / epidemiology*
• Coronavirus Infections / mortality
• Coronavirus Infections / virology
• Drug Interactions
• HIV Infections / drug therapy
• HIV Infections / epidemiology*
• HIV Infections / mortality
• HIV Infections / virology
• HIV-1 / pathogenicity*
• Humans
• Mycobacterium tuberculosis / pathogenicity*
• Pandemics*
• Pneumonia, Viral / drug therapy
• Pneumonia, Viral / epidemiology*
• Pneumonia, Viral / mortality
• Pneumonia, Viral / virology
• Prevalence
• Rifampin / therapeutic use
• SARS-CoV-2
• Survival Analysis
• Tuberculosis, Pulmonary / drug therapy
• Tuberculosis, Pulmonary / epidemiology*
• Tuberculosis, Pulmonary / mortality
• Tuberculosis, Pulmonary / virology
• United States / epidemiology